INTEGRA LIFESCIENCES HLDGS C's ticker is IART and the CUSIP is 457985208. A total of 239 filers reported holding INTEGRA LIFESCIENCES HLDGS C in Q3 2020. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,506,892 | +85.3% | 379,861 | +99.5% | 0.04% | +95.0% |
| Q2 2023 | $7,830,741 | +133.3% | 190,390 | +225.6% | 0.02% | +100.0% |
| Q1 2023 | $3,357,222 | -70.5% | 58,478 | -71.2% | 0.01% | -72.2% |
| Q4 2022 | $11,394,489 | -36.6% | 203,219 | -52.1% | 0.04% | -41.0% |
| Q3 2022 | $17,975,000 | -29.6% | 424,347 | -10.3% | 0.06% | -27.4% |
| Q2 2022 | $25,548,000 | +40.8% | 472,840 | +67.4% | 0.08% | +55.6% |
| Q1 2022 | $18,150,000 | +729.5% | 282,444 | +781.1% | 0.05% | +980.0% |
| Q2 2021 | $2,188,000 | +320.8% | 32,056 | +325.7% | 0.01% | +400.0% |
| Q1 2021 | $520,000 | +143.0% | 7,530 | +65.6% | 0.00% | 0.0% |
| Q2 2020 | $214,000 | -91.8% | 4,548 | -92.3% | 0.00% | -95.2% |
| Q1 2020 | $2,624,000 | -7.7% | 58,737 | +20.4% | 0.02% | +133.3% |
| Q4 2019 | $2,844,000 | -58.5% | 48,796 | -57.2% | 0.01% | -60.9% |
| Q3 2019 | $6,856,000 | +13.6% | 114,127 | +5.6% | 0.02% | +15.0% |
| Q2 2019 | $6,034,000 | +62.9% | 108,035 | +87.9% | 0.02% | +81.8% |
| Q2 2018 | $3,704,000 | +307.5% | 57,510 | +245.0% | 0.01% | +266.7% |
| Q2 2017 | $909,000 | -90.5% | 16,670 | -92.6% | 0.00% | -90.6% |
| Q1 2017 | $9,536,000 | -56.8% | 226,345 | -11.9% | 0.03% | -62.4% |
| Q4 2016 | $22,053,000 | +112.5% | 257,057 | +104.5% | 0.08% | +123.7% |
| Q3 2016 | $10,378,000 | +238.8% | 125,716 | +227.5% | 0.04% | +192.3% |
| Q2 2016 | $3,063,000 | -31.1% | 38,387 | -41.8% | 0.01% | -38.1% |
| Q1 2016 | $4,445,000 | +74.6% | 65,987 | +75.7% | 0.02% | +75.0% |
| Q4 2015 | $2,546,000 | -60.3% | 37,562 | -65.1% | 0.01% | -63.6% |
| Q3 2015 | $6,415,000 | -19.5% | 107,732 | -8.9% | 0.03% | -10.8% |
| Q2 2015 | $7,970,000 | +73.9% | 118,302 | +59.1% | 0.04% | +60.9% |
| Q1 2015 | $4,584,000 | +179.7% | 74,350 | +146.1% | 0.02% | +155.6% |
| Q4 2014 | $1,639,000 | +13.6% | 30,215 | -1.5% | 0.01% | +28.6% |
| Q2 2014 | $1,443,000 | -39.7% | 30,668 | -41.1% | 0.01% | -46.2% |
| Q1 2014 | $2,394,000 | – | 52,063 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VeriStar Capital Management LP | 268,000 | $10,234,920 | 8.72% |
| Madison Avenue Partners, LP | 964,667 | $36,840,633 | 5.23% |
| Pavadi Capital LLC | 99,999 | $3,818,962 | 4.97% |
| KESTREL INVESTMENT MANAGEMENT CORP | 122,450 | $4,676 | 2.96% |
| Sapience Investments, LLC | 245,700 | $9,383,283 | 2.26% |
| Ellsworth Advisors, LLC | 102,500 | $3,882,700 | 1.38% |
| Point72 Europe (London) LLP | 464,462 | $17,737,804 | 1.09% |
| COOKE & BIELER LP | 2,714,194 | $103,655,069 | 1.01% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 75,586 | $2,886,630 | 0.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,126,827 | $43,033,523 | 0.95% |